The 15 most promising biotech companies

FierceBiotech 2009 Fierce 15 winner

Every year our sister publication FierceBiotech publishes the Fierce 15, a list of the most promising private biotech companies. This year's report is made up of drug developers who have vision, good science and solid management that have helped them not only suvive but excel in the face of economic challenges. These biotechs boast ground-breaking technologies that are redefining the biotech industry amidst adverse market conditions. Some of the winning innovations include a potentially new generation of anti-bacterials, advancements in oncology treatments, and cutting-edge developments in the stem cell field.

Click here to see the 2009 Fierce 15 winners. Report

Suggested Articles

Hengrui's Sun Piaoyang is stepping down as chairman, but he'll retain control of the pharma major he's headed for 30 years—and made a fortune…

Astellas tapped Adaptimmune to develop T-cell therapies. Ireland hit Takeda with an unexpected Shire tax bill. PD-1 med Tyvyt hit its goal in NSCLC.

AbbVie and Allergan's merger may create the fourth-largest drugmaker in the world, but it could also create opportunities for other drugmakers.